Advanced
  Home Compare Reports

Comparison with Similar Reports

Wearable Healthcare Devices Market by Product(Trackers, Smartwatch), Type(Diagnostic(BP, Glucose, ECG), Therapeutic(Pain, Insulin)), Grade(Consumer, C...

Publisher:        MarketsandMarkets

# of Pages:        241

Rating: 

1 User License $4,950

Publication Date:  December, 2021

Price:       $4,950 / User License




1 INTRODUCTION 26
1.1 OBJECTIVES OF THE STUDY 26
1.2 MARKET DEFINITION 26
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 27
1.3 MARKETS COVERED 28
FIGURE 1 WEARABLE HEALTHCARE DEVICES MARKET SEGMENTATION 28
1.3.1 YEARS CONSIDERED FOR THE STUDY 29
1.4 CURRENCY 29
1.5 LIMITATIONS 29
1.6 STAKEHOLDERS 30
1.7 SUMMARY OF CHANGES 30
2 RESEARCH METHODOLOGY 32
2.1 RESEARCH DATA 32
2.2 RESEARCH APPROACH 32
FIGURE 2 WEARABLE HEALTHCARE DEVICES MARKET: RESEARCH DESIGN 32
2.2.1 SECONDARY DATA 33
2.2.1.1 Key data from secondary sources 33
2.2.2 PRIMARY DATA 34
2.2.2.1 Key data from primary sources 35
2.2.2.2 Key industry insights 36
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 36
2.3 MARKET SIZE ESTIMATION 37
2.3.1 BOTTOM-UP APPROACH 37
FIGURE 4 WEARABLE HEALTHCARE DEVICES MARKET: BOTTOM-UP APPROACH 37
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 38
2.3.2 TOP-DOWN APPROACH 38
FIGURE 6 WEARABLE HEALTHCARE DEVICES MARKET: TOP-DOWN APPROACH 38
2.4 MARKET BREAKDOWN & DATA TRIANGULATION 39
FIGURE 7 DATA TRIANGULATION METHODOLOGY 39
2.5 ASSUMPTIONS FOR THE STUDY 40
2.6 GROWTH RATE ASSUMPTIONS 40
2.7 LIMITATIONS 41
2.8 RISK ASSESSMENT 41
2.9 COVID-19 HEALTH ASSESSMENT 41
 
2.10 COVID-19 ECONOMIC ASSESSMENT 41
2.11 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 42
FIGURE 8 CRITERIA IMPACTING THE GLOBAL ECONOMY 42
FIGURE 9 RECOVERY SCENARIO OF THE GLOBAL ECONOMY 43
2.12 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE WEARABLE HEALTHCARE
DEVICES MARKET 44
3 EXECUTIVE SUMMARY 45
FIGURE 10 WEARABLE HEALTHCARE DEVICES MARKET, BY PRODUCT,
2021 VS. 2026 (USD MILLION) 45
FIGURE 11 WEARABLE HEALTHCARE DEVICES MARKET, BY GRADE,
2021 VS. 2026 (USD MILLION) 46
FIGURE 12 WEARABLE HEALTHCARE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021 VS. 2026 (USD MILLION) 46
FIGURE 13 WEARABLE HEALTHCARE DEVICES MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION) 47
FIGURE 14 WEARABLE HEALTHCARE DEVICES MARKET, BY REGION,
2021 VS. 2026 (USD MILLION) 48
4 PREMIUM INSIGHTS 49
4.1 WEARABLE HEALTHCARE DEVICES MARKET OVERVIEW 49
FIGURE 15 INCREASING AWARENESS OF FITNESS AND LIFESTYLE TO DRIVE
MARKET GROWTH 49
4.2 WEARABLE HEALTHCARE DEVICES MARKET SHARE, BY PRODUCT, 2021 VS. 2026 50
FIGURE 16 TRACKERS WILL CONTINUE TO DOMINATE THE MARKET IN 2026 50
4.3 WEARABLE HEALTHCARE DEVICES MARKET SHARE, BY TYPE, 2021 VS. 2026 50
FIGURE 17 DIAGNOSTIC & MONITORING DEVICES TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 50
4.4 WEARABLE HEALTHCARE DEVICES MARKET SHARE, BY GRADE, 2021 VS. 2026 51
FIGURE 18 CONSUMER-GRADE WEARABLE HEALTHCARE DEVICES TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 51
4.5 WEARABLE HEALTHCARE DEVICES MARKET SHARE, BY DISTRIBUTION CHANNEL,
2021 VS. 2026 51
FIGURE 19 PHARMACIES ARE THE MOST FREQUENTLY USED DISTRIBUTION CHANNELS 51
4.6 WEARABLE HEALTHCARE DEVICES MARKET SHARE, BY APPLICATION, 2021 VS. 2026 52
FIGURE 20 GENERAL HEALTH AND FITNESS APPLICATIONS TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 52
4.7 WEARABLE HEALTHCARE DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 52
FIGURE 21 NORTH AMERICA TO COMMAND THE LARGEST SHARE AND ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE IN THE WEARABLE HEALTHCARE DEVICES MARKET 52
 
5 MARKET OVERVIEW 53
5.1 INTRODUCTION 53
5.2 MARKET DYNAMICS 53
FIGURE 22 WEARABLE HEALTHCARE DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 53
5.2.1 DRIVERS 54
5.2.1.1 Increasing awareness of fitness, lifestyle, and home healthcare 54
5.2.1.2 Development of technologically advanced products 54
5.2.1.3 Growing geriatric population and subsequent increase in the incidence of chronic diseases 55
5.2.1.4 Growing investments, funds, and grants 56
5.2.1.5 Robust penetration of 3G and 4G networks for uninterrupted healthcare services 57
5.2.1.6 Increasing penetration of smartphones and the growing number of smartphone-based healthcare devices 57
5.2.1.7 Growing preference for wireless connectivity among healthcare providers 57
5.2.2 RESTRAINTS 58
5.2.2.1 Unfavorable standards and regulations 58
5.2.2.2 Issues related to the accuracy, standardization, and analysis of wearable-generated data 59
5.2.2.3 Data security challenges 59
5.2.3 OPPORTUNITIES 60
5.2.3.1 Increasing adoption of artificial intelligence and 5G 60
5.2.4 CHALLENGES 60
5.2.4.1 Patent protection of wearable healthcare devices 60
5.2.4.2 Limited battery life 60
5.2.4.3 Device design complexity 61
5.3 IMPACT OF COVID-19 ON THE WEARABLE HEALTHCARE DEVICES MARKET 61
5.4 PRICING ANALYSIS 62
TABLE 1 PRICES OF WEARABLE HEALTHCARE DEVICES (2021) 62
5.5 PATENT ANALYSIS 63
5.6 TRADE ANALYSIS 63
5.6.1 TRADE ANALYSIS FOR MEDICAL DEVICES 63
TABLE 2 IMPORT DATA FOR MEDICAL DEVICES, BY COUNTRY,
2016–2020 (USD MILLION) 63
TABLE 3 EXPORT DATA FOR MEDICAL DEVICES, BY COUNTRY,
2016–2020 (USD MILLION) 64
5.7 VALUE CHAIN ANALYSIS 64
FIGURE 23 MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASES 64
5.8 SUPPLY CHAIN ANALYSIS 65
FIGURE 24 DISTRIBUTION—A STRATEGY PREFERRED BY PROMINENT COMPANIES 66
 
5.9 ECOSYSTEM ANALYSIS OF THE WEARABLE HEALTHCARE DEVICES MARKET 66
FIGURE 25 WEARABLE HEALTHCARE DEVICES MARKET: ECOSYSTEM ANALYSIS 66
5.9.1 ROLE IN THE ECOSYSTEM 67
5.10 PORTER’S FIVE FORCES ANALYSIS 68
TABLE 4 WEARABLE HEALTHCARE DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 68
5.10.1 THREAT FROM NEW ENTRANTS 68
5.10.2 THREAT FROM SUBSTITUTES 68
5.10.3 BARGAINING POWER OF BUYERS 68
5.10.4 BARGAINING POWER OF SUPPLIERS 68
5.10.5 DEGREE OF COMPETITION 69
5.11 PESTLE ANALYSIS 69
5.12 REGULATORY LANDSCAPE 70
5.12.1 NORTH AMERICA 70
5.12.1.1 US 70
5.12.1.2 Canada 70
5.12.2 ASIA PACIFIC 70
5.12.2.1 Japan 70
5.12.2.2 India 71
5.12.2.3 China 71
5.12.3 LATIN AMERICA 71
5.12.3.1 Brazil 72
5.12.3.2 Mexico 72
5.12.4 MIDDLE EAST 72
5.12.5 AFRICA 72
5.13 TECHNOLOGY ANALYSIS 72
5.14 DISRUPTIVE TECHNOLOGIES IN THE WEARABLE HEALTHCARE DEVICES MARKET 73
5.14.1 REVENUE SHIFT & REVENUE POCKETS FOR THE WEARABLE HEALTHCARE DEVICES MARKET 73
FIGURE 26 REVENUE SHIFT FOR THE WEARABLE HEALTHCARE DEVICES MARKET 73
6 WEARABLE HEALTHCARE DEVICES MARKET, BY PRODUCT 74
6.1 INTRODUCTION 75
TABLE 5 WEARABLE HEALTHCARE DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 75
6.2 TRACKERS 75
6.2.1 GROWING HEALTH CONCERNS DUE TO LIFESTYLE DISEASES TO DRIVE THE GROWTH OF THIS MARKET SEGMENT 75
TABLE 6 TRACKERS OFFERED BY MARKET PLAYERS 76
FIGURE 27 INSIGHTS FROM INDUSTRY EXPERTS ON TRACKERS 76
TABLE 7 WEARABLE HEALTHCARE DEVICES MARKET FOR TRACKERS, BY REGION, 2019–2026 (USD MILLION) 76
 
6.3 SMARTWATCHES 77
6.3.1 EASE OF USE OF SMARTWATCHES WITH GOOD DATA CONNECTIVITY
AND DISPLAY TO BOOST THE DEMAND FOR THESE DEVICES 77
TABLE 8 SMARTWATCHES OFFERED BY MARKET PLAYERS 77
TABLE 9 WEARABLE HEALTHCARE DEVICES MARKET FOR SMARTWATCHES,
BY REGION, 2019–2026 (USD MILLION) 78
6.4 PATCHES 78
6.4.1 HIGH ACCURACY LEVEL OF PATCHES TO DRIVE THEIR DEMAND 78
TABLE 10 PATCHES OFFERED BY MARKET PLAYERS 78
TABLE 11 WEARABLE HEALTHCARE DEVICES MARKET FOR PATCHES, BY REGION, 2019–2026 (USD MILLION) 79
6.5 SMART CLOTHING 79
6.5.1 HYBRID COMBINATION OF CLOTHING WITH ADVANCED FUNCTIONALITIES
TO FUEL THE GROWTH OF THIS MARKET SEGMENT 79
TABLE 12 SMART CLOTHING OFFERED BY MARKET PLAYERS 80
TABLE 13 WEARABLE HEALTHCARE DEVICES MARKET FOR SMART CLOTHING,
BY REGION, 2019–2026 (USD MILLION) 80
7 WEARABLE HEALTHCARE DEVICES MARKET, BY TYPE 81
7.1 INTRODUCTION 82
TABLE 14 WEARABLE HEALTHCARE DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 82
7.2 DIAGNOSTIC & MONITORING DEVICES 82
TABLE 15 WEARABLE DIAGNOSTIC & MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 83
TABLE 16 WEARABLE DIAGNOSTIC & MONITORING DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION) 83
7.2.1 VITAL SIGN MONITORING DEVICES 84
TABLE 17 WEARABLE VITAL SIGN MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 84
TABLE 18 WEARABLE VITAL SIGN MONITORING DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 84
7.2.1.1 Multiparameter trackers 85
7.2.1.1.1 Versatile functionalities offered by multiparameter trackers to drive demand for these devices 85
TABLE 19 WEARABLE MULTIPARAMETER TRACKERS OFFERED BY MARKET PLAYERS 85
TABLE 20 WEARABLE MULTIPARAMETER TRACKERS MARKET, BY REGION,
2019–2026 (USD MILLION) 86
7.2.1.2 ECG/heart rate monitors 86
7.2.1.2.1 Ability to continuously monitor critical cardiac parameters to drive the demand for ECG/heart rate monitors 86
TABLE 21 WEARABLE ECG/HEART RATE MONITORS OFFERED BY MARKET PLAYERS 87
TABLE 22 WEARABLE ECG/HEART RATE MONITORS MARKET, BY REGION,
2019–2026 (USD MILLION) 88
7.2.1.3 Blood pressure monitors 88
7.2.1.3.1 Rising incidence of hypertension to drive the growth of this segment 88
TABLE 23 WEARABLE BLOOD PRESSURE MONITORS OFFERED BY MARKET PLAYERS 89
TABLE 24 WEARABLE BLOOD PRESSURE MONITORS MARKET, BY REGION,
2019–2026 (USD MILLION) 89
7.2.1.4 Pulse oximeters 90
7.2.1.4.1 Continuous monitoring of oxygenation levels is of critical importance in hospitals and other critical care settings 90
TABLE 25 WEARABLE PULSE OXIMETERS OFFERED BY MARKET PLAYERS 90
TABLE 26 WEARABLE PULSE OXIMETERS MARKET, BY REGION,
2019–2026 (USD MILLION) 91
7.2.2 GLUCOSE MONITORING DEVICES 91
7.2.2.1 Increasing incidence of diabetes to drive the growth of this market segment 91
TABLE 27 WEARABLE GLUCOSE MONITORING DEVICES OFFERED BY MARKET PLAYERS 92
TABLE 28 WEARABLE GLUCOSE MONITORING DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 92
7.2.3 SLEEP MONITORING DEVICES 92
7.2.3.1 Continuous monitoring of sleep patterns helps identify the root cause of sleep-related disorders 92
TABLE 29 WEARABLE SLEEP MONITORING DEVICES OFFERED BY MARKET PLAYERS 93
TABLE 30 WEARABLE SLEEP MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 93
TABLE 31 WEARABLE SLEEP MONITORING DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 94
7.2.3.1.1 Wrist actigraphs 94
7.2.3.1.1.1 Increasing focus on assessing actimeter performance contributes to market growth 94
TABLE 32 WEARABLE WRIST ACTIGRAPHS MARKET, BY REGION,
2019–2026 (USD MILLION) 94
7.2.3.1.2 Polysomnography devices 95
7.2.3.1.2.1 Awareness on the diagnosis of sleep-related disorders to drive the market segment 95
TABLE 33 WEARABLE POLYSOMNOGRAPHY DEVICES OFFERED BY MARKET PLAYERS 95
TABLE 34 WEARABLE POLYSOMNOGRAPHY DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 95
7.2.4 FETAL MONITORING AND OBSTETRIC DEVICES 96
7.2.4.1 Rising focus on better care and monitoring during pregnancy to drive the growth of this market segment 96
TABLE 35 WEARABLE FETAL MONITORING AND OBSTETRIC DEVICES OFFERED
BY MARKET PLAYERS 96
TABLE 36 WEARABLE FETAL MONITORING AND OBSTETRIC DEVICES MARKET,
BY REGION, 2019–2026 (USD MILLION) 97
7.2.5 NEUROMONITORING DEVICES 97
7.2.5.1 Major advantages of these devices such as enhanced portability and ease of use to drive the market growth 97
TABLE 37 WEARABLE NEUROMONITORING DEVICES OFFERED BY MARKET PLAYERS 98
TABLE 38 WEARABLE NEUROMONITORING DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 98
7.3 THERAPEUTIC DEVICES 99
TABLE 39 WEARABLE THERAPEUTIC DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 99
TABLE 40 WEARABLE THERAPEUTIC DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 99
7.3.1 PAIN MANAGEMENT DEVICES 100
7.3.1.1 Rising incidence of chronic pain to drive the demand for pain management devices 100
TABLE 41 WEARABLE PAIN MANAGEMENT DEVICES OFFERED BY MARKET PLAYERS 100
TABLE 42 WEARABLE PAIN MANAGEMENT DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 100
7.3.2 REHABILITATION DEVICES 101
7.3.2.1 Rising need for easy and home rehabilitation of patients to support the growth of this market segment 101
TABLE 43 WEARABLE REHABILITATION DEVICES OFFERED BY MARKET PLAYERS 101
TABLE 44 WEARABLE REHABILITATION DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 101
7.3.3 RESPIRATORY THERAPY DEVICES 102
7.3.3.1 Increasing incidence of COPD to drive the demand for respiratory therapy devices 102
TABLE 45 WEARABLE RESPIRATORY THERAPY DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 102
7.3.4 INSULIN PUMPS 102
7.3.4.1 Growing need for self-monitoring and the delivery of insulin to support the growth of this market segment 102
TABLE 46 WEARABLE INSULIN PUMPS MARKET, BY REGION,
2019–2026 (USD MILLION) 103
8 WEARABLE HEALTHCARE DEVICES MARKET, BY GRADE 104
8.1 INTRODUCTION 105
TABLE 47 WEARABLE HEALTHCARE DEVICES MARKET, BY GRADE,
2019–2026 (USD MILLION) 105
8.2 CONSUMER-GRADE WEARABLE HEALTHCARE DEVICES 105
8.2.1 EASY AVAILABILITY AND LOW COST OF CONSUMER-GRADE DEVICES TO SUPPORT THE GROWTH OF THIS MARKET SEGMENT 105
TABLE 48 EXAMPLES OF CONSUMER-GRADE WEARABLE HEALTHCARE DEVICES 106
TABLE 49 CONSUMER-GRADE WEARABLE HEALTHCARE DEVICES MARKET,
BY REGION, 2019–2026 (USD MILLION) 107
8.3 CLINICAL-GRADE WEARABLE HEALTHCARE DEVICES 107
8.3.1 HIGH ACCURACY WITH INCREASED CLINICAL USE TO DRIVE THE DEMAND FOR CLINICAL-GRADE WEARABLE HEALTHCARE DEVICES 107
TABLE 50 EXAMPLES OF CLINICAL-GRADE WEARABLE HEALTHCARE DEVICES 108
TABLE 51 CLINICAL-GRADE WEARABLE HEALTHCARE DEVICES MARKET,
BY REGION, 2019–2026 (USD MILLION) 108
 
9 WEARABLE HEALTHCARE DEVICES MARKET, BY DISTRIBUTION CHANNEL 109
9.1 INTRODUCTION 110
TABLE 52 WEARABLE HEALTHCARE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 110
9.2 PHARMACIES 110
9.2.1 SUBSTANTIAL INCREASE IN SUPPLY OF WEARABLE DEVICES IN PHARMACIES TO SUPPORT THE GROWTH OF THIS MARKET SEGMENT 110
TABLE 53 WEARABLE HEALTHCARE DEVICES MARKET FOR PHARMACIES, BY REGION, 2019–2026 (USD MILLION) 111
9.3 ONLINE CHANNELS 111
9.3.1 EASE OF USE AND HIGH LEVELS OF CONVENIENCE HAVE MADE ONLINE SALES A PROMINENT PART OF DISTRIBUTION 111
TABLE 54 WEARABLE HEALTHCARE DEVICES MARKET FOR ONLINE CHANNELS,
BY REGION, 2019–2026 (USD MILLION) 112
9.4 HYPERMARKETS 112
9.4.1 GROWTH OF RETAIL BUSINESSES AND INCREASING SCOPE OF HYPERMARKETS TO DRIVE THIS SEGMENT 112
TABLE 55 WEARABLE HEALTHCARE DEVICES MARKET FOR HYPERMARKETS,
BY REGION, 2019–2026 (USD MILLION) 113
10 WEARABLE HEALTHCARE DEVICES MARKET, BY APPLICATION 114
10.1 INTRODUCTION 115
TABLE 56 WEARABLE HEALTHCARE DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 115
10.2 GENERAL HEALTH AND FITNESS 115
10.2.1 GROWING FOCUS ON MONITORING HEALTH AND FITNESS WILL BOOST GROWTH IN THIS MARKET SEGMENT 115
TABLE 57 WEARABLE HEALTHCARE DEVICES MARKET FOR GENERAL HEALTH
AND FITNESS APPLICATIONS, BY REGION, 2019–2026 (USD MILLION) 116
10.3 REMOTE PATIENT MONITORING 116
10.3.1 ADVANTAGES SUCH AS EASE OF SHARING DATA RECORDS AND COST SAVINGS TO DRIVE THE DEMAND FOR THESE DEVICES 116
TABLE 58 WEARABLE HEALTHCARE DEVICES MARKET FOR REMOTE PATIENT MONITORING APPLICATIONS, BY REGION, 2019–2026 (USD MILLION) 117
10.4 HOME HEALTHCARE 117
10.4.1 REDUCED COST AND CONTINUOUS MONITORING OF VITAL INFORMATION IN HOME SETTINGS TO BOOST GROWTH 117
TABLE 59 WEARABLE HEALTHCARE DEVICES MARKET FOR HOME HEALTHCARE APPLICATIONS, BY REGION, 2019–2026 (USD MILLION) 118
11 WEARABLE HEALTHCARE DEVICES MARKET, BY REGION 119
11.1 INTRODUCTION 120
TABLE 60 WEARABLE HEALTHCARE DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 120
11.2 NORTH AMERICA 120
FIGURE 28 NORTH AMERICA: WEARABLE HEALTHCARE DEVICES MARKET SNAPSHOT 121
TABLE 61 NORTH AMERICA: WEARABLE HEALTHCARE DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 122
TABLE 62 NORTH AMERICA: WEARABLE HEALTHCARE DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 122
TABLE 63 NORTH AMERICA: WEARABLE HEALTHCARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 122
TABLE 64 NORTH AMERICA: WEARABLE DIAGNOSTIC & MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 123
TABLE 65 NORTH AMERICA: WEARABLE VITAL SIGN MONITORING DEVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 123
TABLE 66 NORTH AMERICA: WEARABLE THERAPEUTIC DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 124
TABLE 67 NORTH AMERICA: WEARABLE HEALTHCARE DEVICES MARKET,
BY GRADE, 2019–2026 (USD MILLION) 124
TABLE 68 NORTH AMERICA: WEARABLE HEALTHCARE DEVICES MARKET,
BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 124
TABLE 69 NORTH AMERICA: WEARABLE HEALTHCARE DEVICES MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 125
11.2.1 US 125
11.2.1.1 Presence of various federal mandates that encourage the adoption of eHealth among healthcare providers to drive market growth in the US 125
TABLE 70 US: WEARABLE HEALTHCARE DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 126
TABLE 71 US: WEARABLE HEALTHCARE DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 126
TABLE 72 US: WEARABLE DIAGNOSTIC & MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 126
TABLE 73 US: WEARABLE VITAL SIGN MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 127
TABLE 74 US: WEARABLE THERAPEUTIC DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 127
TABLE 75 US: WEARABLE HEALTHCARE DEVICES MARKET, BY GRADE,
2019–2026 (USD MILLION) 127
TABLE 76 US: WEARABLE HEALTHCARE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 128
TABLE 77 US: WEARABLE HEALTHCARE DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 128
11.2.2 CANADA 128
11.2.2.1 Increasing number of start-ups investing in wearable device-related research to fuel market growth in Canada 128
TABLE 78 CANADA: WEARABLE HEALTHCARE DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 129
TABLE 79 CANADA: WEARABLE HEALTHCARE DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 129
TABLE 80 CANADA: WEARABLE DIAGNOSTIC & MONITORING DEVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 130
TABLE 81 CANADA: WEARABLE VITAL SIGN MONITORING DEVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 130
TABLE 82 CANADA: WEARABLE THERAPEUTIC DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 131
TABLE 83 CANADA: WEARABLE HEALTHCARE DEVICES MARKET, BY GRADE,
2019–2026 (USD MILLION) 131
TABLE 84 CANADA: WEARABLE HEALTHCARE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 131
TABLE 85 CANADA: WEARABLE HEALTHCARE DEVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 132
11.3 EUROPE 132
TABLE 86 EUROPE: WEARABLE HEALTHCARE DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 132
TABLE 87 EUROPE: WEARABLE HEALTHCARE DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 133
TABLE 88 EUROPE: WEARABLE HEALTHCARE DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 133
TABLE 89 EUROPE: WEARABLE DIAGNOSTIC & MONITORING DEVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 133
TABLE 90 EUROPE: WEARABLE VITAL SIGN MONITORING DEVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 134
TABLE 91 EUROPE: WEARABLE THERAPEUTIC DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 134
TABLE 92 EUROPE: WEARABLE HEALTHCARE DEVICES MARKET, BY GRADE,
2019–2026 (USD MILLION) 134
TABLE 93 EUROPE: WEARABLE HEALTHCARE DEVICES MARKET,
BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 135
TABLE 94 EUROPE: WEARABLE HEALTHCARE DEVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 135
11.3.1 GERMANY 135
11.3.1.1 Growing preference for home monitoring to boost market growth in Germany 135
TABLE 95 GERMANY: WEARABLE HEALTHCARE DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 136
TABLE 96 GERMANY: WEARABLE HEALTHCARE DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 136
TABLE 97 GERMANY: WEARABLE DIAGNOSTIC & MONITORING DEVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 137
TABLE 98 GERMANY: WEARABLE VITAL SIGN MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 137
TABLE 99 GERMANY: WEARABLE THERAPEUTIC DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 138
TABLE 100 GERMANY: WEARABLE HEALTHCARE DEVICES MARKET, BY GRADE,
2019–2026 (USD MILLION) 138
TABLE 101 GERMANY: WEARABLE HEALTHCARE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 138
TABLE 102 GERMANY: WEARABLE HEALTHCARE DEVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 139
11.3.2 UK 139
11.3.2.1 Increasing incidence of chronic diseases to drive market growth in the UK 139
TABLE 103 UK: WEARABLE HEALTHCARE DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 140
TABLE 104 UK: WEARABLE HEALTHCARE DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 140
TABLE 105 UK: WEARABLE DIAGNOSTIC & MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 140
TABLE 106 UK: WEARABLE VITAL SIGN MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 141
TABLE 107 UK: WEARABLE THERAPEUTIC DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 141
TABLE 108 UK: WEARABLE HEALTHCARE DEVICES MARKET, BY GRADE,
2019–2026 (USD MILLION) 141
TABLE 109 UK: WEARABLE HEALTHCARE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 142
TABLE 110 UK: WEARABLE HEALTHCARE DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 142
11.3.3 FRANCE 142
11.3.3.1 Growing geriatric population to drive the demand for vital sign monitoring devices in France 142
TABLE 111 FRANCE: WEARABLE HEALTHCARE DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 143
TABLE 112 FRANCE: WEARABLE HEALTHCARE DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 143
TABLE 113 FRANCE: WEARABLE DIAGNOSTIC & MONITORING DEVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 144
TABLE 114 FRANCE: WEARABLE VITAL SIGN MONITORING DEVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 144
TABLE 115 FRANCE: WEARABLE THERAPEUTIC DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 145
TABLE 116 FRANCE: WEARABLE HEALTHCARE DEVICES MARKET, BY GRADE,
2019–2026 (USD MILLION) 145
TABLE 117 FRANCE: WEARABLE HEALTHCARE DEVICES MARKET,
BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 145
TABLE 118 FRANCE: WEARABLE HEALTHCARE DEVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 146
11.3.4 ITALY 146
11.3.4.1 Growing adoption of mobile devices among healthcare professionals to support market growth in Italy 146
TABLE 119 ITALY: WEARABLE HEALTHCARE DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 147
TABLE 120 ITALY: WEARABLE HEALTHCARE DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 147
TABLE 121 ITALY: WEARABLE DIAGNOSTIC & MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 147
TABLE 122 ITALY: WEARABLE VITAL SIGN MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 148
TABLE 123 ITALY: WEARABLE THERAPEUTIC DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 148
TABLE 124 ITALY: WEARABLE HEALTHCARE DEVICES MARKET, BY GRADE,
2019–2026 (USD MILLION) 148
TABLE 125 ITALY: WEARABLE HEALTHCARE DEVICES MARKET,
BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 149
TABLE 126 ITALY: WEARABLE HEALTHCARE DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 149
11.3.5 SPAIN 149
11.3.5.1 Initiatives to promote mHealth solutions to support the growth of the market in Spain 149
TABLE 127 SPAIN: WEARABLE HEALTHCARE DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 150
TABLE 128 SPAIN: WEARABLE HEALTHCARE DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 150
TABLE 129 SPAIN: WEARABLE DIAGNOSTIC & MONITORING DEVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 150
TABLE 130 SPAIN: WEARABLE VITAL SIGN MONITORING DEVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 151
TABLE 131 SPAIN: WEARABLE THERAPEUTIC DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 151
TABLE 132 SPAIN: WEARABLE HEALTHCARE DEVICES MARKET, BY GRADE,
2019–2026 (USD MILLION) 151
TABLE 133 SPAIN: WEARABLE HEALTHCARE DEVICES MARKET,
BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 152
TABLE 134 SPAIN: WEARABLE HEALTHCARE DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 152
11.3.6 REST OF EUROPE 152
TABLE 135 ROE: WEARABLE HEALTHCARE DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 153
TABLE 136 ROE: WEARABLE HEALTHCARE DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 153
TABLE 137 ROE: WEARABLE DIAGNOSTIC & MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 153
TABLE 138 ROE: WEARABLE VITAL SIGN MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 154
TABLE 139 ROE: WEARABLE THERAPEUTIC DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 154
TABLE 140 ROE: WEARABLE HEALTHCARE DEVICES MARKET, BY GRADE,
2019–2026 (USD MILLION) 154
TABLE 141 ROE: WEARABLE HEALTHCARE DEVICES MARKET,
BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 155
TABLE 142 ROE: WEARABLE HEALTHCARE DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 155
11.4 ASIA PACIFIC 155
FIGURE 29 ASIA PACIFIC: WEARABLE HEALTHCARE DEVICES MARKET SNAPSHOT 156
TABLE 143 ASIA PACIFIC: WEARABLE HEALTHCARE DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 157
TABLE 144 ASIA PACIFIC: WEARABLE HEALTHCARE DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 157
TABLE 145 ASIA PACIFIC: WEARABLE HEALTHCARE DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 157
TABLE 146 ASIA PACIFIC: WEARABLE DIAGNOSTIC & MONITORING DEVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 158
TABLE 147 ASIA PACIFIC: WEARABLE VITAL SIGN MONITORING DEVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 158
TABLE 148 ASIA PACIFIC: WEARABLE THERAPEUTIC DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 159
TABLE 149 ASIA PACIFIC: WEARABLE HEALTHCARE DEVICES MARKET, BY GRADE,
2019–2026 (USD MILLION) 159
TABLE 150 ASIA PACIFIC: WEARABLE HEALTHCARE DEVICES MARKET,
BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 159
TABLE 151 ASIA PACIFIC: WEARABLE HEALTHCARE DEVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 160
11.4.1 CHINA 160
11.4.1.1 Presence of a large number of wearable healthcare device manufacturers to propel market growth 160
TABLE 152 CHINA: WEARABLE HEALTHCARE DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 161
TABLE 153 CHINA: WEARABLE HEALTHCARE DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 161
TABLE 154 CHINA: WEARABLE DIAGNOSTIC & MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 161
TABLE 155 CHINA: WEARABLE VITAL SIGN MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 162
TABLE 156 CHINA: WEARABLE THERAPEUTIC DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 162
TABLE 157 CHINA: WEARABLE HEALTHCARE DEVICES MARKET, BY GRADE,
2019–2026 (USD MILLION) 162
TABLE 158 CHINA: WEARABLE HEALTHCARE DEVICES MARKET,
BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 163
TABLE 159 CHINA: WEARABLE HEALTHCARE DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 163
11.4.2 JAPAN 163
11.4.2.1 Growing geriatric population and rising focus on home monitoring
to drive the market in Japan 163
TABLE 160 JAPAN: WEARABLE HEALTHCARE DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 164
TABLE 161 JAPAN: WEARABLE HEALTHCARE DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 164
TABLE 162 JAPAN: WEARABLE DIAGNOSTIC & MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 165
TABLE 163 JAPAN: WEARABLE VITAL SIGN MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 165
TABLE 164 JAPAN: WEARABLE THERAPEUTIC DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 166
TABLE 165 JAPAN: WEARABLE HEALTHCARE DEVICES MARKET, BY GRADE,
2019–2026 (USD MILLION) 166
TABLE 166 JAPAN: WEARABLE HEALTHCARE DEVICES MARKET,
BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 166
TABLE 167 JAPAN: WEARABLE HEALTHCARE DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 167
11.4.3 INDIA 167
11.4.3.1 Rising disposable income levels enhance consumer access to advanced medical technologies 167
TABLE 168 INDIA: WEARABLE HEALTHCARE DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 168
TABLE 169 INDIA: WEARABLE HEALTHCARE DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 168
TABLE 170 INDIA: WEARABLE DIAGNOSTIC & MONITORING DEVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 168
TABLE 171 INDIA: WEARABLE VITAL SIGN MONITORING DEVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 169
TABLE 172 INDIA: WEARABLE THERAPEUTIC DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 169
TABLE 173 INDIA: WEARABLE HEALTHCARE DEVICES MARKET, BY GRADE,
2019–2026 (USD MILLION) 169
TABLE 174 INDIA: WEARABLE HEALTHCARE DEVICES MARKET,
BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 170
TABLE 175 INDIA: WEARABLE HEALTHCARE DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 170
11.4.4 AUSTRALIA & NEW ZEALAND 170
11.4.4.1 Growing digitalization and increasing preference for home monitoring to boost market growth 170
TABLE 176 AUSTRALIA & NEW ZEALAND: WEARABLE HEALTHCARE DEVICES MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 171
TABLE 177 AUSTRALIA & NEW ZEALAND: WEARABLE HEALTHCARE DEVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 171
TABLE 178 AUSTRALIA & NEW ZEALAND: WEARABLE DIAGNOSTIC & MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 172
TABLE 179 AUSTRALIA & NEW ZEALAND: WEARABLE VITAL SIGN MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 172
TABLE 180 AUSTRALIA & NEW ZEALAND: WEARABLE THERAPEUTIC DEVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 173
TABLE 181 AUSTRALIA & NEW ZEALAND: WEARABLE HEALTHCARE DEVICES MARKET,
BY GRADE, 2019–2026 (USD MILLION) 173
TABLE 182 AUSTRALIA & NEW ZEALAND: WEARABLE HEALTHCARE DEVICES MARKET,
BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 173
TABLE 183 AUSTRALIA & NEW ZEALAND: WEARABLE HEALTHCARE DEVICES MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 174
11.4.5 REST OF ASIA PACIFIC 174
TABLE 184 ROAPAC: WEARABLE HEALTHCARE DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 175
TABLE 185 ROAPAC: WEARABLE HEALTHCARE DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 175
TABLE 186 ROAPAC: WEARABLE DIAGNOSTIC & MONITORING DEVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 175
TABLE 187 ROAPAC: WEARABLE VITAL SIGN MONITORING DEVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 176
TABLE 188 ROAPAC: WEARABLE THERAPEUTIC DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 176
TABLE 189 ROAPAC: WEARABLE HEALTHCARE DEVICES MARKET, BY GRADE,
2019–2026 (USD MILLION) 176
TABLE 190 ROAPAC: WEARABLE HEALTHCARE DEVICES MARKET,
BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 177
TABLE 191 ROAPAC: WEARABLE HEALTHCARE DEVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 177
11.5 LATIN AMERICA 177
11.5.1 EFFECTIVE IMPLEMENTATION OF MOBILITY HEALTH DEVICES TO REDUCE TOTAL HEALTHCARE EXPENDITURE WILL FUEL MARKET GROWTH 177
TABLE 192 LATIN AMERICA: WEARABLE HEALTHCARE DEVICES MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 178
TABLE 193 LATIN AMERICA: WEARABLE HEALTHCARE DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 178
TABLE 194 LATIN AMERICA: WEARABLE DIAGNOSTIC & MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 178
TABLE 195 LATIN AMERICA: WEARABLE VITAL SIGN MONITORING DEVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 179
TABLE 196 LATIN AMERICA: WEARABLE THERAPEUTIC DEVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 179
TABLE 197 LATIN AMERICA: WEARABLE HEALTHCARE DEVICES MARKET,
BY GRADE, 2019–2026 (USD MILLION) 179
TABLE 198 LATIN AMERICA: WEARABLE HEALTHCARE DEVICES MARKET,
BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 180
TABLE 199 LATIN AMERICA: WEARABLE HEALTHCARE DEVICES MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 180
11.6 MIDDLE EAST & AFRICA 180
11.6.1 GROWING ADOPTION OF DISRUPTIVE SOLUTIONS WILL BOOST THE DEMAND FOR WEARABLE HEALTHCARE DEVICES IN THIS REGION 180
TABLE 200 MIDDLE EAST & AFRICA: WEARABLE HEALTHCARE DEVICES MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 181
TABLE 201 MIDDLE EAST & AFRICA: WEARABLE HEALTHCARE DEVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 181
TABLE 202 MIDDLE EAST & AFRICA: WEARABLE DIAGNOSTIC & MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 182
TABLE 203 MIDDLE EAST & AFRICA: WEARABLE VITAL SIGN MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 182
TABLE 204 MIDDLE EAST & AFRICA: WEARABLE THERAPEUTIC DEVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 183
TABLE 205 MIDDLE EAST & AFRICA: WEARABLE HEALTHCARE DEVICES MARKET,
BY GRADE, 2019–2026 (USD MILLION) 183
TABLE 206 MIDDLE EAST & AFRICA: WEARABLE HEALTHCARE DEVICES MARKET,
BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 184
TABLE 207 MIDDLE EAST & AFRICA: WEARABLE HEALTHCARE DEVICES MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 184

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127